Procurement Opportunity: INJ ATROPINE,INJ HAEMOCEAL,INJ VALLETHAMIDE,INJ CARBOPLAST,INJ TRAMAXIC ACID,INJ BHPIVACAINE IN DEX in RAJAURI, JAMMU & KASHMIR

The eligibility requirements for the tender involve being a registered entity in the pharmaceutical sector, complying with all relevant licensing and regulatory norms, and demonstrating previous experience in supplying similar injectable medications. Companies should also present necessary certifications that comply with national standards.

Bidders must provide clear details regarding the technical specifications of the injectable medications offered. This includes compliance with pharmacopoeia standards and necessary certifications from health authorities confirming the efficacy and safety of the injectable formulations.

To comply with the quality standards stipulated in the tender, bidders are required to submit quality assurance certifications, manufacturing licenses, and any other relevant documents showing adherence to established quality control protocols in the production of injectable medications.

The submission must be done electronically via the specified portal. All documents required for the tender, including technical and financial proposals, need to be uploaded in the acceptable file formats mentioned in the tender documentation. Proper labeling and organization of documents are essential for a smooth evaluation process.

Yes, the tender includes provisions for Micro, Small, and Medium Enterprises (MSEs), allowing them certain advantages such as modified eligibility criteria, and potential support in the evaluation process. This aligns with government initiatives to promote MSE participation in procurement opportunities, encouraging local production and economic growth.

This detailed description and the FAQs should assist potential bidders in understanding the tender's requirements thoroughly and preparing their submissions effectively.